Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (372) 372
Patent (36) 36
Conference Proceeding (14) 14
Publication (9) 9
Book Chapter (1) 1
Book Review (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (129) 129
index medicus (106) 106
male (92) 92
middle aged (88) 88
female (85) 85
gastroenterology & hepatology (82) 82
aged (70) 70
adult (57) 57
gastroenterology and hepatology (47) 47
cancer (42) 42
medicine & public health (36) 36
pancreatic cancer (36) 36
retrospective studies (32) 32
tumors (32) 32
diagnosis (31) 31
endoscopic ultrasonography (27) 27
oncology (27) 27
pancreatic neoplasms - pathology (27) 27
surgery (27) 27
aged, 80 and over (26) 26
chemotherapy (26) 26
gastroenterology (25) 25
carcinoma (24) 24
treatment outcome (24) 24
endosonography (22) 22
hepatology (22) 22
prognosis (22) 22
surgical oncology (21) 21
pancreas (20) 20
survival (20) 20
japan (19) 19
pancreatic neoplasms - diagnosis (19) 19
patients (18) 18
physics (18) 18
abdominal surgery (17) 17
analysis (17) 17
colorectal surgery (17) 17
biopsy (15) 15
fine-needle-aspiration (15) 15
gemcitabine (15) 15
pancreatic neoplasms - drug therapy (15) 15
animals (14) 14
endoscopic ultrasound (14) 14
metastasis (14) 14
pancreatic neoplasms - diagnostic imaging (14) 14
pancreatitis (14) 14
time factors (14) 14
care and treatment (13) 13
diagnosis, differential (13) 13
digestive system diseases (13) 13
endocrinology & metabolism (13) 13
endoscopic ultrasound-guided fine needle aspiration (13) 13
original article (13) 13
pancreatic neoplasms - genetics (13) 13
risk factors (13) 13
therapy (13) 13
autoimmune pancreatitis (12) 12
measuring (12) 12
recurrence (12) 12
testing (12) 12
deoxycytidine - analogs & derivatives (11) 11
follow-up studies (11) 11
management (11) 11
original (11) 11
pancreatic neoplasms - surgery (11) 11
predictive value of tests (11) 11
adenocarcinoma (10) 10
biopsy, fine-needle (10) 10
case-control studies (10) 10
endoscopic ultrasonography-guided biliary drainage (10) 10
endosonography - methods (10) 10
engineering, biomedical (10) 10
sensitivity and specificity (10) 10
stents (10) 10
case report (9) 9
drainage (9) 9
endoscopy (9) 9
hospitals (9) 9
immunohistochemistry (9) 9
internal medicine (9) 9
medical prognosis (9) 9
medicine, general & internal (9) 9
pathology (9) 9
research (9) 9
transplantation (9) 9
ultrasonography (9) 9
antigens (8) 8
colonoscopy (8) 8
expression (8) 8
features (8) 8
metastases (8) 8
oncology, experimental (8) 8
pancreas - pathology (8) 8
studies (8) 8
adenocarcinoma - pathology (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
autoimmune diseases - diagnosis (7) 7
autoimmune diseases - drug therapy (7) 7
biopsy, fine-needle - methods (7) 7
confidence intervals (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012
by Ohara, Hirotaka and Okazaki, Kazuichi and Tsubouchi, Hirohito and Inui, Kazuo and Kawa, Shigeyuki and Kamisawa, Terumi and Tazuma, Susumu and Uchida, Kazushige and Hirano, Kenji and Yoshida, Hitoshi and Nishino, Takayoshi and Ko, Shigeru B. H and Mizuno, Nobumasa and Hamano, Hideaki and Kanno, Atsushi and Notohara, Kenji and Hasebe, Osamu and Nakazawa, Takahiro and Nakanuma, Yasuni and Takikawa, Hajime and Ministry of Health, Labor and Welfare, Japan and Japan Biliary Association and Research Committee of IgG4-related Diseases and Research Committee of Intractable Diseases of Liver and Biliary Tract
Journal of Hepato-Biliary-Pancreatic Sciences, ISSN 1868-6974, 9/2012, Volume 19, Issue 5, pp. 536 - 542
IgG4-sclerosing cholangitis (IgG4-SC) patients have an increased level of serum IgG4, dense infiltration of IgG4-positive plasma cells with extensive fibrosis... 
Pathology | Medicine & Public Health | Diagnostic Radiology | Gastroenterology | Abdominal Surgery | Internal Medicine | IgG4 | Primary sclerosing cholangitis | Sclerosing cholangitis | Surgical Oncology | Autoimmune pancreatitis | Cholangiocarcinoma | autoimmune pancreatitis | cholangiocarcinoma | primary sclerosing cholangitis | sclerosing cholangitis | LIVER-BIOPSY | BILE-DUCT | INVOLVEMENT | IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS | EXTRAPANCREATIC LESIONS | IGG4-ASSOCIATED CHOLANGITIS | CHOLANGIOGRAPHY | SPECTRUM | GASTROENTEROLOGY & HEPATOLOGY | Cholangitis, Sclerosing - pathology | Diagnosis, Differential | Immunoglobulin G - blood | Pancreatic Neoplasms - diagnosis | Humans | Cholangitis, Sclerosing - blood | Cholangitis, Sclerosing - diagnosis | Bile Ducts - pathology | Biliary Tract Neoplasms - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: A comparison study with EUS-FNA
by Mizuno, Nobumasa and Bhatia, Vikram and Hosoda, Waki and Sawaki, Akira and Hoki, Noriyuki and Hara, Kazuo and Takagi, Tadayuki and Ko, Shigeru B.H and Yatabe, Yasushi and Goto, Hidemi and Yamao, Kenji
Journal of Gastroenterology, ISSN 0944-1174, 2009, Volume 44, Issue 7, pp. 742 - 750
Purpose The aim of this study was to evaluate the feasibility and safety of endoscopic ultrasonography (EUS)guided trucut biopsy (TCB) for diagnosis of... 
AIP | EUS-TCB | LPSP | Pancreatic cancer | CRITERIA | LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS | CANCER | FEATURES | INFILTRATION | FINE-NEEDLE-ASPIRATION | ENDOSCOPIC ULTRASONOGRAPHY | EXPERIENCE | 19-GAUGE | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | Biopsy, Fine-Needle - methods | Ultrasonography, Interventional - methods | Humans | Middle Aged | Male | Autoimmune Diseases - diagnosis | Biopsy, Needle - methods | Endosonography - adverse effects | Feasibility Studies | Pancreatitis - diagnosis | Ultrasonography, Interventional - adverse effects | Endosonography - methods | Adult | Female | Pancreatitis - pathology | Aged | Retrospective Studies | Autoimmune Diseases - pathology | Medical colleges | Diagnostic imaging | Diagnosis | Immunoglobulin G | Pancreatitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience
by Haba, Shin and Yamao, Kenji and Bhatia, Vikram and Mizuno, Nobumasa and Hara, Kazuo and Hijioka, Susumu and Imaoka, Hiroshi and Niwa, Yasumasa and Tajika, Masahiro and Kondo, Shinya and Tanaka, Tsutomu and Shimizu, Yasuhiro and Yatabe, Yasushi and Hosoda, Waki and Kawakami, Hiroshi and Sakamoto, Naoya
Journal of Gastroenterology, ISSN 0944-1174, 8/2013, Volume 48, Issue 8, pp. 973 - 981
Several studies have investigated the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for pancreatic lesions, but they... 
On-site evaluation | Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) | Accuracy | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Pancreatic solid lesion | Surgical Oncology | Cell-block examination | MASSES | OBSTRUCTIVE-JAUNDICE | MANAGEMENT | BIOPSY | CANCER | TUMORS | EUS-FNA | MALIGNANCY | IMPACT | GASTROENTEROLOGY & HEPATOLOGY | Multivariate Analysis | Predictive Value of Tests | Pancreatic Neoplasms - diagnosis | Humans | Japan | Middle Aged | Pancreatic Diseases - diagnosis | Pancreatic Neoplasms - pathology | Male | Pancreatic Diseases - pathology | Young Adult | Sensitivity and Specificity | Aged, 80 and over | Endoscopic Ultrasound-Guided Fine Needle Aspiration - methods | Adult | Female | Aged | Retrospective Studies | Benign
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms
by Hijioka, Susumu and Hara, Kazuo and Mizuno, Nobumasa and Okuno, Nozomi and Bhatia, Vikram
Journal of Gastroenterology, ISSN 0944-1174, 2/2017, Volume 52, Issue 2, pp. 264 - 264
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00535-016-1297-7 
Abdominal Surgery | Medicine & Public Health | Colorectal Surgery | Surgical Oncology | Hepatology | Gastroenterology | GASTROENTEROLOGY & HEPATOLOGY | Neuroendocrine Tumors | Biopsy, Fine-Needle | Endosonography | Humans | Retrospective Studies | Pancreatic Neoplasms | Endoscopic Ultrasound-Guided Fine Needle Aspiration | Liver | Diagnosis | Tumors | Letter to the Editor
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS‐PC Study
by Yamaue, Hiroki and Tsunoda, Takuya and Tani, Masaji and Miyazawa, Motoki and Yamao, Kenji and Mizuno, Nobumasa and Okusaka, Takuji and Ueno, Hideki and Boku, Narikazu and Fukutomi, Akira and Ishii, Hiroshi and Ohkawa, Shinichi and Furukawa, Masayuki and Maguchi, Hiroyuki and Ikeda, Masafumi and Togashi, Yosuke and Nishio, Kazuto and Ohashi, Yasuo
Cancer Science, ISSN 1347-9032, 07/2015, Volume 106, Issue 7, pp. 883 - 890
Gemcitabine is a key drug for the treatment of pancreatic cancer; however, with its limitation in clinical benefits, the development of another potent... 
phase II/III | elpamotide | Advanced pancreatic cancer | peptide vaccine | immunotherapy | Peptide vaccine | Elpamotide | Immunotherapy | Phase II/III | PLUS GEMCITABINE | 1ST-LINE TREATMENT | ENDOTHELIAL-GROWTH-FACTOR | FACTOR RECEPTOR-2 | EPITOPE-PEPTIDES | METASTATIC COLORECTAL-CANCER | CELL LUNG-CANCER | ONCOLOGY | POOR-PROGNOSIS | III TRIAL | COOPERATIVE-ONCOLOGY-GROUP | Adenocarcinoma - pathology | Carcinoma, Adenosquamous - pathology | Double-Blind Method | Cancer Vaccines - administration & dosage | Deoxycytidine - administration & dosage | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Peptide Fragments - administration & dosage | Kaplan-Meier Estimate | Carcinoma, Adenosquamous - drug therapy | Male | Treatment Outcome | Adenocarcinoma - drug therapy | Pancreatic Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Adenosquamous - mortality | Adult | Female | Aged | Pancreatic Neoplasms - mortality | Vascular Endothelial Growth Factor Receptor-2 - administration & dosage | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Statistical analysis | Gemcitabine | Peptides | Toxicity | Clinical trials | Metastasis | Radiation therapy | Cancer therapies | Survival | Patients | Blood | Metastases | Angiogenesis | Chemotherapy | Pancreatic cancer | Medical prognosis | Vascular endothelial growth factor receptor 2 | Vascular endothelial growth factor | Index Medicus | phase II | III | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients
by Kubota, Kensuke and Kamisawa, Terumi and Okazaki, Kazuichi and Kawa, Shigeyuki and Hirano, Kenji and Hirooka, Yoshiki and Uchida, Kazushige and Shiomi, Hideyuki and Ohara, Hirotaka and Shimizu, Kyoko and Arakura, Norikazu and Kanno, Atsushi and Sakagami, Junichi and Itoi, Takao and Ito, Tetsuhide and Ueki, Toshiharu and Nishino, Takayoshi and Inui, Kazuo and Mizuno, Nobumasa and Yoshida, Hitoshi and Sugiyama, Masanori and Iwasaki, Eisuke and Irisawa, Atshishi and Shimosegawa, Toru and Takeyama, Yoshifumi and Chiba, Tsutomu
Journal of Gastroenterology, ISSN 0944-1174, 8/2017, Volume 52, Issue 8, pp. 955 - 964
The effect of maintenance steroid treatment (MST) in reducing the risk of relapse in patients with autoimmune pancreatitis (AIP) remains under debate. The aim... 
Steroid toxicity | Medicine & Public Health | Maintenance steroid treatment | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Relapse rate | Surgical Oncology | Autoimmune pancreatitis | DIAGNOSIS | MANAGEMENT | PROGNOSIS | GUIDELINES | THERAPY | HEPATITIS | DISEASE | SCLEROSING PANCREATITIS | GASTROENTEROLOGY & HEPATOLOGY | Pancreatitis, Chronic - immunology | Prednisolone - adverse effects | Recurrence | Azathioprine - therapeutic use | Prednisolone - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Japan | Middle Aged | Risk Factors | Male | Secondary Prevention | Anti-Inflammatory Agents - adverse effects | Time Factors | Pancreatitis, Chronic - drug therapy | Anti-Inflammatory Agents - administration & dosage | Female | Aged | Maintenance Chemotherapy | Autoimmune Diseases - drug therapy | Relapse | Care and treatment | Analysis | Pancreatitis | Diseases | Side effects | Pancreas | Health risk assessment | Toxicity | Patients | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
by Ogura, Takeshi and Yamao, Kenji and Hara, Kazuo and Mizuno, Nobumasa and Hijioka, Susumu and Imaoka, Hiroshi and Sawaki, Akira and Niwa, Yasumasa and Tajika, Masahiro and Kondo, Shinya and Tanaka, Tsutomu and Shimizu, Yasuhiro and Bhatia, Vikram and Higuchi, Kazuhide and Hosoda, Waki and Yatabe, Yasushi
Journal of Gastroenterology, ISSN 0944-1174, 5/2013, Volume 48, Issue 5, pp. 640 - 646
Although recent reports indicate that K-ras mutation status is a biomarker that acts as a prognostic factor, only a few analyses of K-ras mutation subtypes... 
K - ras mutation | Medicine & Public Health | Colorectal Surgery | Hepatology | Pancreatic cancer | Gastroenterology | Abdominal Surgery | Surgical Oncology | Subtype | EUS-FNA | K-ras mutation | SURVIVAL | DIAGNOSIS | DUCTAL ADENOCARCINOMA | TUMORS | CETUXIMAB | IMPACT | COLORECTAL-CANCER | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | EXPRESSION | PROGRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Male | Pancreatic Neoplasms - genetics | Proto-Oncogene Proteins - genetics | Aged, 80 and over | Pancreatic Neoplasms - classification | Adult | Female | Aged | Retrospective Studies | Mutation | Genes, ras | Endoscopic Ultrasound-Guided Fine Needle Aspiration | Pancreatic Neoplasms - diagnostic imaging | Medical colleges | Liver cancer | Chemotherapy | Endoscopic ultrasonography | Analysis | Genetic aspects | Cancer | Age
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms
by Hijioka, Susumu and Hara, Kazuo and Mizuno, Nobumasa and Imaoka, Hiroshi and Bhatia, Vikram and Mekky, Mohamed A and Yoshimura, Kenichi and Yoshida, Tsukasa and Okuno, Nozomi and Hieda, Nobuhiro and Tajika, Masahiro and Tanaka, Tsutomu and Ishihara, Makoto and Yatabe, Yasushi and Shimizu, Yasuhiro and Niwa, Yasumasa and Yamao, Kenji
Journal of Gastroenterology, ISSN 0944-1174, 9/2016, Volume 51, Issue 9, pp. 923 - 930
Multiple studies have investigated sampling adequacy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for pancreatic neuroendocrine neoplasms... 
Pancreatic neuroendocrine neoplasms | Medicine & Public Health | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | Surgical Oncology | Diagnosability | EUS-FNA | CONTROLLED-TRIAL | TISSUE ACQUISITION | TUMORS | PUNCTURE | KI-67 INDEX | SPECIMENS | FINE-NEEDLE-ASPIRATION | ENDOSCOPIC ULTRASOUND | ULTRASONOGRAPHY | GASTROENTEROLOGY & HEPATOLOGY | SUCTION | Neuroendocrine Tumors - pathology | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Male | Neuroendocrine Tumors - diagnostic imaging | Sensitivity and Specificity | Adult | Female | Neuroendocrine Tumors - surgery | Aged | Retrospective Studies | Endoscopic Ultrasound-Guided Fine Needle Aspiration | Pancreatic Neoplasms - diagnostic imaging | Analysis | Diagnosis | Tumors | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
by Hijioka, Susumu and Hosoda, Waki and Mizuno, Nobumasa and Hara, Kazuo and Imaoka, Hiroshi and Bhatia, Vikram and Mekky, Mohamed A and Tajika, Masahiro and Tanaka, Tsutomu and Ishihara, Makoto and Yogi, Tatsuji and Tsutumi, Hideharu and Fujiyoshi, Toshihisa and Sato, Takamitsu and Hieda, Nobuhiro and Yoshida, Tsukasa and Okuno, Nozomi and Shimizu, Yasuhiro and Yatabe, Yasushi and Niwa, Yasumasa and Yamao, Kenji
Journal of Gastroenterology, ISSN 0944-1174, 5/2015, Volume 50, Issue 5, pp. 564 - 572
The WHO classified pancreatic neuroendocrine neoplasms in 2010 as G1, G2, and neuroendocrine carcinoma (NEC), according to the Ki67 labeling index (LI).... 
KRAS mutation | Ki67 labeling index | Medicine & Public Health | Colorectal Surgery | Hepatology | Neuroendocrine carcinoma | Gastroenterology | Abdominal Surgery | Surgical Oncology | WHO classification | PROGNOSTIC-FACTORS | GUIDELINES | ENDOCRINE TUMORS | FNA SPECIMENS | ENETS | CENTER EXPERIENCE | KI-67 | FINE-NEEDLE-ASPIRATION | ENDOSCOPIC ULTRASOUND | SMALL-CELL | GASTROENTEROLOGY & HEPATOLOGY | Prognosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Carcinoma, Neuroendocrine - therapy | Male | Neoplasm Grading | Pancreatic Neoplasms - classification | Adult | Female | Pancreatic Neoplasms - mortality | Retrospective Studies | Endoscopic Ultrasound-Guided Fine Needle Aspiration | Carcinoma, Neuroendocrine - mortality | Reproducibility of Results | World Health Organization | Carcinoma, Neuroendocrine - classification | Pancreatic Neoplasms - pathology | Carcinoma, Neuroendocrine - genetics | Pancreatic Neoplasms - genetics | Ki-67 Antigen - genetics | Carcinoma, Neuroendocrine - pathology | Aged | Biomarkers, Tumor - genetics | Mutation | Neoplasm Staging | Pancreatic Neoplasms - therapy | Chemotherapy | Analysis | Tumors | Cancer | Index Medicus | Original —Liver, Pancreas, and Biliary Tract
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer
by Ueno, Hideki and Ikeda, Masafumi and Ueno, Makoto and Mizuno, Nobumasa and Ioka, Tatsuya and Omuro, Yasushi and Nakajima, Takako Eguchi and Furuse, Junji
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2016, Volume 77, Issue 3, pp. 595 - 603
Efficacy and safety of nab-paclitaxel plus gemcitabine have not been clarified in Japanese patients with metastatic pancreatic cancer. No pharmacokinetic... 
Medicine & Public Health | Gemcitabine | Combination chemotherapy | Pancreatic cancer | Oncology | Cancer Research | Nab -paclitaxel | Pharmacology/Toxicology | Pharmacokinetics | Nab-paclitaxel | SURVIVAL | FOLFIRINOX | LUNG-CANCER | ONCOLOGY | ALBUMIN-BOUND PACLITAXEL | S-1 | PHARMACOLOGY & PHARMACY | 1ST-LINE THERAPY | III TRIAL | Follow-Up Studies | Deoxycytidine - administration & dosage | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Albumins - administration & dosage | Male | Survival Rate | Treatment Outcome | Pancreatic Neoplasms - drug therapy | Disease-Free Survival | Asian Continental Ancestry Group | Neoplasm Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Paclitaxel - administration & dosage | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical research | Cancer patients | Chemotherapy | Analysis | Medicine, Experimental | Development and progression | Metastasis | Antineoplastic agents | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis
by Masamune, Atsushi and Nishimori, Isao and Kikuta, Kazuhiro and Tsuji, Ichiro and Mizuno, Nobumasa and Iiyama, Tatsuo and Kanno, Atsushi and Tachibana, Yuichi and Ito, Tetsuhide and Kamisawa, Terumi and Uchida, Kazushige and Hamano, Hideaki and Yasuda, Hiroaki and Sakagami, Junichi and Mitoro, Akira and Taguchi, Masashi and Kihara, Yasuyuki and Sugimoto, Hiroyuki and Hirooka, Yoshiki and Yamamoto, Satoshi and Inui, Kazuo and Inatomi, Osamu and Andoh, Akira and Nakahara, Kazuyuki and Miyakawa, Hiroyuki and Hamada, Shin and Kawa, Shigeyuki and Okazaki, Kazuichi and Shimosegawa, Tooru and Res Comm Intractable Pancreas Dis and Research Committee of Intractable Pancreas Diseases in Japan
Gut, ISSN 0017-5749, 03/2017, Volume 66, Issue 3, pp. 487 - 494
ObjectiveCorticosteroid has been established as the standard therapy for autoimmune pancreatitis (AIP), but the requirement for maintenance corticosteroid... 
autoimmune disease | Pancreatic disease | RELAPSE | IGG4-RELATED DISEASE | MULTICENTER | MALIGNANCY | CLINICAL PROFILE | CHOLANGITIS | STEROID-THERAPY | OUTCOMES | DIAGNOSTIC-CRITERIA | TYPE-1 | GASTROENTEROLOGY & HEPATOLOGY | Prednisolone - adverse effects | Recurrence | Prednisolone - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Pancreatitis - drug therapy | Withholding Treatment | Disease-Free Survival | Anti-Inflammatory Agents - adverse effects | Time Factors | Anti-Inflammatory Agents - administration & dosage | Female | Aged | Maintenance Chemotherapy | Autoimmune Diseases - drug therapy | Usage | Care and treatment | Corticosteroids | Pancreatic diseases | Diagnosis | Patients | Health aspects | Studies | Disease | Pancreatic cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors
by Mekky, Mohamed A., MD and Yamao, Kenji, MD and Sawaki, Akira, MD and Mizuno, Nobumasa, MD and Hara, Kazuo, MD and Nafeh, Mohamed A., MD and Osman, Ashraf M., MD and Koshikawa, Takashi, MD and Yatabe, Yasushi, MD and Bhatia, Vikram, MD
Gastrointestinal Endoscopy, ISSN 0016-5107, 2010, Volume 71, Issue 6, pp. 913 - 919
Background Submucosal tumors (SMTs) comprise both benign and malignant lesions, and most of the gastric lesions tend to be malignant. The addition of... 
Gastroenterology and Hepatology | TRACT | DIFFERENTIAL-DIAGNOSIS | FINE-NEEDLE-ASPIRATION | IMMUNOHISTOCHEMICAL ANALYSIS | YIELD | BIOPSY | ENDOSCOPIC-ULTRASOUND | GASTROENTEROLOGY & HEPATOLOGY | GASTROINTESTINAL STROMAL TUMORS | LESIONS | STOMACH | Immunohistochemistry | Stomach Neoplasms - diagnosis | Endosonography | Humans | Middle Aged | Gastric Mucosa - pathology | Male | Stomach Neoplasms - pathology | Biopsy, Fine-Needle | Adult | Female | Aged | Retrospective Studies | Care and treatment | Diagnosis | Tumors | Financial disclosure
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights